This is a discussion on Pfizer halts Phase III cancer trial on poor results within the Biotechnology News forum, part of the Industry News and Updates category; Pfizer's big push into cancer drugs has hit a snag. The company announced that it is halting a late-...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
|||
|
Pfizer's big push into cancer drugs has hit a snag. The company announced that it is halting a late-stage trial of tremelimumab for advanced melanoma after researchers concluded it was no more Read more...
More... |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| SPOTLIGHT: Cancer drug flunks Phase III | industry_news | Biotechnology News | 0 | 03-19-2008 09:08 AM |
| Rare disease puts Phase III vax trial on hold | industry_news | Biotechnology News | 0 | 03-19-2008 09:08 AM |
| GSK successful in Phase III inflammation trial | industry_news | Biotechnology News | 0 | 03-19-2008 09:08 AM |